Tagged: RESI

  • April 27, 2017

    R&E Search for Evidence: New FHI 360 blog leverages research and evaluation to advance development solutions

    Written by
    Annette N. Brown, Editor-in-Chief, R&E Search for Evidence blog

    FHI 360’s Research and Evaluation Strategic Initiative team is pleased to report that we have already published 15 posts in FHI 360’s newest blog, R&E Search for Evidence, since its launch in February. The R&E Search for Evidence blog features posts that engage readers with discussions of innovative methodologies, evidence reviews and analyses of recent journal publications. We focus on delivering in-depth coverage of research and evaluation methods and findings to better address the world’s most complex human development challenges.

    Stay tuned for what’s to come on “R&E Search for Evidence” in future weeks. Weekly blog posts will continue to feature the analysis of FHI 360 thought leaders to promote a culture of generating and using evidence for making development solutions a reality. Upcoming posts will explore the evaluation of quality improvement programming, additional guidance on sampling, promising evidence on integrated development and much more!

    Continue reading

  • March 13, 2017

    Should PEPFAR be renamed the “President’s Epidemiologic Plan for AIDS Relief”?

    Written by
    Dr. Timothy Mastro, Chief Science Officer, FHI 360

    The full version of this post originally appeared on R&E Search for Evidence. Reposted with permission.

    The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is a remarkable success story built on the effective use of data. The achievements of this landmark initiative have played a central role in getting us to the point where we can finally talk about controlling the HIV epidemic and creating an AIDS-free generation.

    Through 2016, US$70 billion has been invested in this unprecedented disease control effort. The accomplishments to date have been extraordinary and unimaginable just a few years ago: In 2016 alone, 74 million people were tested for HIV infection; since the start of PEPFAR, 2 million babies were born HIV-free due to women receiving prevention of mother-to-child HIV transmission (PMTCT) treatment; 12 million voluntary medical male circumcisions have been performed; and PEPFAR accounted for 12 million of the 18 million people globally receiving life-extending antiretroviral therapy (ART).

    Continue reading